non-small cell lung cancer

AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
Fri, 05/25/18 - 08:59 am
AstraZeneca
Imfinzi
non-small cell lung cancer
Rain Therapeutics nets $18M to push lung cancer asset into phase 2
Fierce Biotech
Mon, 05/21/18 - 09:15 am
Rain Therapeutics
non-small cell lung cancer
Neon Therapeutics Treats First Patient in Ph Ib Trial Evaluating Personal Cancer Vaccine NEO-PV-01 Plus Keytruda/Chemo Combination
Tue, 05/8/18 - 10:26 am
Neon Therapeutics
cancer vaccines
NEO-PV-01
non-small cell lung cancer
EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
Thu, 05/3/18 - 09:24 am
Bristol-Myers Squibb
non-small cell lung cancer
Opdivo
Yervoy
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
CP Wire
Wed, 04/25/18 - 09:55 am
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Tue, 04/24/18 - 11:17 pm
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
CP Wire
Thu, 04/19/18 - 12:30 am
Roche
cobas EGFR Mutation Test
Tagrisso
non-small cell lung cancer
AstraZeneca
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
Thu, 04/19/18 - 12:13 am
Roche
Tagrisso
non-small cell lung cancer
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 02/19/18 - 11:42 am
AstraZeneca
FDA
Imfinzi
non-small cell lung cancer
AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA
Yahoo/Zacks.com
Tue, 12/19/17 - 10:24 am
AstraZeneca
Tagrisso
FDA
labeling
non-small cell lung cancer
Most Damaging Clinical Trial Failure: AstraZeneca's MYSTIC
BioPharma Dive
Mon, 12/4/17 - 09:42 pm
clinical trials
AstraZeneca
Mystic
Imfinzi
non-small cell lung cancer
Recent Developments for Merck’s Keytruda
Market Realist
Fri, 12/1/17 - 12:02 pm
Merck
Keytruda
immuno-oncology
anti-PD-1 immunotherapy
non-small cell lung cancer
AstraZeneca touts Tagrisso's CNS benefit
BioPharma Dive
Tue, 11/21/17 - 09:45 am
Tagrisso
AstraZeneca
non-small cell lung cancer
CNS metastases
Here's Why Merck & Co., Inc. Tanked 14% in October
Motley Fool
Wed, 11/8/17 - 06:20 pm
Merck
Keytruda
Europe
non-small cell lung cancer
FDA adds fresh ‘breakthrough’ for Novartis’ cancer combo Tafinlar and Mekinist
Endpoints
Mon, 10/23/17 - 09:57 am
FDA
Novartis
Tafinlar
Mekinist
non-small cell lung cancer
Hunting an early FDA OK, Ignyta surges on promising snapshot of lung cancer data
Endpoints
Wed, 10/18/17 - 09:24 am
Ignyta
entrectinib
non-small cell lung cancer
After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorlatinib, heads to the FDA
Endpoints
Mon, 10/16/17 - 12:00 pm
Pfizer
lorlatinib
FDA
non-small cell lung cancer
Lilly's lung cancer drug fails main goal of key study
Yahoo/Reuters
Tue, 10/10/17 - 09:35 am
Eli Lilly
lung cancer
clinical trials
Verzenio
non-small cell lung cancer

Pages